128 related articles for article (PubMed ID: 21515420)
1. A PEGylated fibrin-based wound dressing with antimicrobial and angiogenic activity.
Seetharaman S; Natesan S; Stowers RS; Mullens C; Baer DG; Suggs LJ; Christy RJ
Acta Biomater; 2011 Jul; 7(7):2787-96. PubMed ID: 21515420
[TBL] [Abstract][Full Text] [Related]
2. A PEGylated fibrin hydrogel-based antimicrobial wound dressing controls infection without impeding wound healing.
Gil J; Natesan S; Li J; Valdes J; Harding A; Solis M; Davis SC; Christy RJ
Int Wound J; 2017 Dec; 14(6):1248-1257. PubMed ID: 28771993
[TBL] [Abstract][Full Text] [Related]
3. Delivery of silver sulfadiazine and adipose derived stem cells using fibrin hydrogel improves infected burn wound regeneration.
Banerjee J; Seetharaman S; Wrice NL; Christy RJ; Natesan S
PLoS One; 2019; 14(6):e0217965. PubMed ID: 31194776
[TBL] [Abstract][Full Text] [Related]
4. Impregnation of silver sulfadiazine into bacterial cellulose for antimicrobial and biocompatible wound dressing.
Luan J; Wu J; Zheng Y; Song W; Wang G; Guo J; Ding X
Biomed Mater; 2012 Dec; 7(6):065006. PubMed ID: 23182757
[TBL] [Abstract][Full Text] [Related]
5. Design and delivery of silver sulfadiazine from alginate microspheres-impregnated collagen scaffold.
Shanmugasundaram N; Sundaraseelan J; Uma S; Selvaraj D; Babu M
J Biomed Mater Res B Appl Biomater; 2006 May; 77(2):378-88. PubMed ID: 16278846
[TBL] [Abstract][Full Text] [Related]
6. Benefit of hydrocolloid SSD dressing in the outpatient management of partial thickness burns.
Muangman P; Muangman S; Opasanon S; Keorochana K; Chuntrasakul C
J Med Assoc Thai; 2009 Oct; 92(10):1300-5. PubMed ID: 19845237
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Wound Dressing Containing Silver Sulfadiazine With High Biocompatibility: In Vitro Study.
Mohseni M; Shamloo A; Aghababaei Z; Vossoughi M; Moravvej H
Artif Organs; 2016 Aug; 40(8):765-73. PubMed ID: 27094090
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial efficacy of the silver wound dressing Biatain Ag in a disc carrier test simulating wound secretion.
Ebert M; Assadian O; Hübner NO; Koburger T; Kramer A; ;
Skin Pharmacol Physiol; 2011; 24(6):337-41. PubMed ID: 21832866
[TBL] [Abstract][Full Text] [Related]
9. Using chitosan nanoparticles as drug carriers for the development of a silver sulfadiazine wound dressing.
El-Feky GS; Sharaf SS; El Shafei A; Hegazy AA
Carbohydr Polym; 2017 Feb; 158():11-19. PubMed ID: 28024533
[TBL] [Abstract][Full Text] [Related]
10. Possibility of wound dressing using poly(L-leucine)/poly(ethylene glycol)/poly(L-leucine) triblock copolymer.
Kim HJ; Choi EY; Oh JS; Lee HC; Park SS; Cho CS
Biomaterials; 2000 Jan; 21(2):131-41. PubMed ID: 10632395
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial dressing of silver sulfadiazine-loaded halloysite/cassava starch-based (bio)nanocomposites.
da Silva GLP; Morais LCA; Olivato JB; Marini J; Ferrari PC
J Biomater Appl; 2021 Apr; 35(9):1096-1108. PubMed ID: 33611961
[TBL] [Abstract][Full Text] [Related]
12. Functionally modified gelatin microspheres impregnated collagen scaffold as novel wound dressing to attenuate the proteases and bacterial growth.
Adhirajan N; Shanmugasundaram N; Shanmuganathan S; Babu M
Eur J Pharm Sci; 2009 Feb; 36(2-3):235-45. PubMed ID: 18952165
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity of silver sulfadiazine, alone and in combination with cerium nitrate, against staphylococci and gram-negative bacteria.
Marone P; Monzillo V; Perversi L; Carretto E
J Chemother; 1998 Feb; 10(1):17-21. PubMed ID: 9531070
[TBL] [Abstract][Full Text] [Related]
14. An in vitro test of the efficacy of silver-containing wound dressings against Staphylococcus aureus and Pseudomonas aeruginosa in simulated wound fluid.
Said J; Dodoo CC; Walker M; Parsons D; Stapleton P; Beezer AE; Gaisford S
Int J Pharm; 2014 Feb; 462(1-2):123-8. PubMed ID: 24374221
[TBL] [Abstract][Full Text] [Related]
15. Silver sulfadiazine loaded chitosan/chondroitin sulfate films for a potential wound dressing application.
Fajardo AR; Lopes LC; Caleare AO; Britta EA; Nakamura CV; Rubira AF; Muniz EC
Mater Sci Eng C Mater Biol Appl; 2013 Mar; 33(2):588-95. PubMed ID: 25427460
[TBL] [Abstract][Full Text] [Related]
16. Dealing with biofilms of Pseudomonas aeruginosa and Staphylococcus aureus: In vitro evaluation of a novel aerosol formulation of silver sulfadiazine.
Moyano AJ; Mas CR; Colque CA; Smania AM
Burns; 2020 Feb; 46(1):128-135. PubMed ID: 31420266
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro antimicrobial activity of silver sulfadiazine and cerium nitrate.
Saffer LD; Rodeheaver GT; Hiebert JM; Edlich RF
Surg Gynecol Obstet; 1980 Aug; 151(2):232-6. PubMed ID: 6773164
[TBL] [Abstract][Full Text] [Related]
18. Delivery of the topical antimicrobial agents silver sulfadiazine, gentamicin and nystatin to infected burn wounds in rats from preloaded synthetic dressings.
Robb EC; Fitz DG; Nathan P
Trans Am Soc Artif Intern Organs; 1980; 26():533-6. PubMed ID: 6787772
[TBL] [Abstract][Full Text] [Related]
19. Antibiofilm Potential of Silver Sulfadiazine-Loaded Nanoparticle Formulations: A Study on the Effect of DNase-I on Microbial Biofilm and Wound Healing Activity.
Patel KK; Surekha DB; Tripathi M; Anjum MM; Muthu MS; Tilak R; Agrawal AK; Singh S
Mol Pharm; 2019 Sep; 16(9):3916-3925. PubMed ID: 31318574
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.
Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST
J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
